Biomea Fusion Files Q1 2025 10-Q
Ticker: BMEA · Form: 10-Q · Filed: May 5, 2025 · CIK: 1840439
| Field | Detail |
|---|---|
| Company | Biomea Fusion, Inc. (BMEA) |
| Form Type | 10-Q |
| Filed Date | May 5, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, pharmaceutical, SEC filing
Related Tickers: BMEA
TL;DR
BMEA Q1 2025 10-Q filed. Financials updated, including stock and capital. ATM offerings detailed.
AI Summary
Biomea Fusion, Inc. filed its 10-Q for the period ending March 31, 2025. The company reported on its financial position, including common stock and additional paid-in capital. Key financial activities and balances from Q1 2024 and Q1 2025 are detailed, alongside information on equity incentive plans and various ATM offerings.
Why It Matters
This filing provides investors with an update on Biomea Fusion's financial health and capital structure as of the first quarter of 2025, crucial for assessing its ongoing operational capacity and investment potential.
Risk Assessment
Risk Level: medium — The filing contains financial data for a company in the pharmaceutical sector, which inherently carries risks related to drug development and market approval.
Key Numbers
- 2025-03-31 — Reporting Period End Date (Indicates the latest financial snapshot provided.)
- 2025-05-05 — Filing Date (Shows when the 10-Q was officially submitted to the SEC.)
- Q1 2025 — Fiscal Quarter (Specifies the period covered by the financial report.)
Key Players & Entities
- Biomea Fusion, Inc. (company) — Filer of the 10-Q
- March 31, 2025 (date) — End of the reporting period
- 0000950170-25-063543 (other) — Accession Number for the filing
- PHARMACEUTICAL PREPARATIONS [2834] (industry) — Standard Industrial Classification
- 900 MIDDLEFIELD ROAD, REDWOOD CITY, CA 94063 (address) — Business and mailing address
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is March 31, 2025.
What is the company's Standard Industrial Classification (SIC) code?
The company's SIC code is PHARMACEUTICAL PREPARATIONS [2834].
What is the business address of Biomea Fusion, Inc.?
The business address is 900 MIDDLEFIELD ROAD, 4TH FLOOR, REDWOOD CITY, CA 94063.
When was this 10-Q form filed with the SEC?
This 10-Q form was filed on May 5, 2025.
What specific financial elements are mentioned in relation to the reporting period?
The filing mentions elements such as us-gaap:CommonStockMember, us-gaap:AdditionalPaidInCapitalMember, and various ATM offering agreements (bmea:AtTheMarketOfferingMember, bmea:TwoThousandTwentyTwoATMAgreementMember) for the period ending March 31, 2025.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 5, 2025 regarding Biomea Fusion, Inc. (BMEA).